Protein Technologies, Inc. Achieves Growth and Success Since 2006 Award

Protein Technologies, Inc. Achieves Growth and Success Since 2006 Award

Protein Technologies, Inc. (PTI), named one of the Top 50 Arizona Companies to Watch in 2006 (the first year of this award), has truly earned its title. Co-sponsored by the Arizona Small Business Association (ASBA) and the Edward Lowe Foundation, this award was designed to honor outstanding second stage-companies in Arizona.

According to then Arizona Governor Janet Napolitano, "Second-stage companies are privately held enterprises that employ from 10 to 100 people and generate between $750,000 and $100 million in gross annual sales. They are navigating an exciting if tumultuous stage of growth that presents challenges and opportunities different from those faced by startup companies or large corporations….The "Companies to Watch" awards identify and celebrate businesses moving successfully through this crucial second-stage of growth."

Since receiving the award, Protein Technologies has enjoyed double digit growth every year from 2007 through 2010. Achieving double-digit growth for a company even in good times is an amazing feat. It is an extraordinary one in financial times like these, and PTI has now done it for the fourth year in a row! PTI’s successful growth started with having a firm base of reliable, high performance instrumentation, including our very first peptide synthesizer, the PS3™, which celebrated its 20th anniversary in 2010. A fantastic basic unit, it created such a great first impression that not only are inaugural instruments still running in some labs, but some labs refuse to buy anything else! Likewise, we are proud to say that our SYMPHONY^® line has been the main workhorse of the custom peptide industry over the last 18 years.

In the last 5 years, PTI has lead the market in innovative instrument design with the expansion of our product line starting with the release of the PRELUDE^® Parallel Peptide Synthesizer in 2006, and the TRIBUTE^® peptide synthesizer in 2007. The IntelliSynth™ UV-Monitoring and Feedback Control System option for the TRIBUTE™ and the new larger capacity SONATA^® XT peptide synthesizer were released in 2009. The new OVERTURE™ Robotic Peptide Library Synthesizer was released in 2010, which is PTI’s first instrument geared towards the peptide library market with features never before seen on robotic units of its class.

As PTI celebrates its 26^th anniversary in 2011, we have truly reached our goal of being the world’s leading manufacturer of peptide synthesizers, and look forward to continuing to provide the best products, service, and support in the industry as we strive to do even better in the years to come!

Protein Technologies, Inc. is a private company located in Tucson, AZ that specializes in the manufacture and distribution of high quality peptide synthesizers and reagents. PTI peptide synthesizers have a reputation for their high performance, flexibility and reliability, and are based on a unique, patented matrix block technology. PTI has placed hundreds of peptide synthesizers in academic institutions, biotechnology companies and pharmaceutical companies worldwide, and strives to provide the best service to its customers through both technical and chemistry support. For more information about Protein Technologies, visit: www.peptideinstruments.com.

INQUIRIES: Protein Technologies, Inc.,

Attn: Christina Chantell, 4675 South Coach Drive, Tucson, AZ 85714. Or e-mail to info@ptipep.com.